Plain-English translation of NCT04801290 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study follows patients who receive a transjugular intrahepatic portosystemic shunt (TIPS)—a procedure where doctors create a small passage inside the liver to relieve pressure and improve blood flow in patients with advanced liver cirrhosis. By collecting medical data and blood samples from participants over time, researchers aim to better understand which patients benefit most from this procedure and how to optimize its use.
Advanced liver disease often causes dangerous complications from high pressure in the liver's blood vessels. This study exists to clarify which patients are the best candidates for this procedure and how doctors can improve outcomes for people with decompensated cirrhosis.
You likely qualify if…
You likely don't qualify if…
If you join this registry, you will receive the liver shunt procedure as planned by your doctor. Alongside your regular treatment, the research team will collect your medical information and take blood samples at various points to track your health and response to the procedure. This is an observational study, meaning researchers will monitor and record data rather than ask you to do anything beyond your standard medical care.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Germany
Enrollment target
~250 participants
Started
August 2019
Primary completion
December 2027
Age range
18 Years – 99 Years
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Benjamin Maasoumy, PD
Hannover Medical School
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.